Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Healthy Participants × capivasertib × Clear all

Phase

Status

Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Leukemia 1 Healthy Participants 1 Exanthema 1 Diarrhea 1

Interventions

capivasertib 1 Dextromethorphan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07241065 2025-11-21

A Study to Investigate the Effect of Capivasertib on the Pharmacokinetics of Oral Dextromethorphan (CYP2D6 Substrate) in Healthy Participants

AstraZeneca

Phase 1 Not yet recruiting

Healthy Participants

Data powered by HemOnc (CC BY 4.0) Colophon ⚡